Transcranial brain parenchyma sonography in movement disorders: State of the art

Ultrasound in Medicine and Biology

Volumn 33, Issue 1, 2007, Pages 15-25

  Walter, Uwe ^a   Behnke, Stefanie ^b   Eyding, Jens ^c   Niehaus, Ludwig ^d   Postert, Thomas ^c,e   Seidel, Günter ^f   Berg, Daniela ^g,h  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e St Vincenz Hospital   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g UNIVERSITY OF TÜBINGEN   (Germany)

^h UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Brain parenchyma sonography; Caudate nucleus; Cerebellum; Consensus; Lenticular nucleus; Movement disorder; Neurodegenerative disease; Substantia nigra; Transcranial sonography; Ventricle width

Indexed keywords

BLOOD VESSELS; BRAIN; DISEASES; HEMODYNAMICS; NEUROLOGY;

CAUDATE NUCLEUS; CEREBELLUM; CONSENSUS; LENTICULAR NUCLEUS; MOVEMENT DISORDER; NEURODEGENERATIVE DISEASES; SUBSTANTIA NIGRA; TRANSCRANIAL BRAIN PARENCHYMA SONOGRAPHY; VENTRICLE WIDTH;

ULTRASONICS;

AGITATION; BRAIN TISSUE; CEREBELLUM TENTORIUM; DEGENERATIVE DISEASE; DOPPLER ECHOGRAPHY; ECHOGRAPHY; FUNCTIONAL ASSESSMENT; HEMODYNAMICS; HUMAN; IDIOPATHIC DISEASE; MOTOR DYSFUNCTION; NIGRONEOSTRIATAL SYSTEM; NON INVASIVE MEASUREMENT; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA;

EID: 33845628890     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2006.07.021     Document Type: Review

References (49)

1. Bandmann O., Asmus F., Sibbing D., et al. Copper genes are not implicated in the pathogenesis of focal dystonia. Neurology 59 (2002) 782-783
2. Becker G., and Berg D. Neuroimaging in basal ganglia disorders: Perspectives for transcranial ultrasound. Mov Disord 16 (2001) 23-32
3. Becker G., Struck M., Bogdahn U., and Becker T. Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res 55 (1994) 75-84
4. Becker G., Seufert J., Bogdahn U., Reichmann H., and Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 45 (1995) 182-184
5. Becker G., Becker T., Struck M., et al. Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol Psychiatry 38 (1995) 180-184
6. Becker T., Becker G., Seufert J., et al. Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63 (1997) 590-596
7. Becker G., Naumann M., Scheubeck M., et al. Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis. Mov Disord 12 (1997) 79-88
8. Becker G., Berg D., Rausch W.D., et al. Increased tissue copper and manganese content of the lentiform nucleus in primary adult-onset dystonia. Ann Neurol 46 (1999) 260-263
9. Becker G., Berg D., Francis M., and Naumann M. Evidence for disturbances of copper metabolism in dystonia. From the image towards a new concept. Neurology 57 (2001) 2290-2294
10. Becker G., Berg D., Kruse N., et al. Evidence for shoulder girdle dystonia in selected patients with cervical disc prolapse. Mov Disord 17 (2002) 710 --716
11. Behnke S., Berg D., Naumann M., and Becker G. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76 (2005) 423-425
12. Berg D., Becker G., Zeiler B., et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53 (1999) 1026-1031
13. Berg D., Supprian T., Hofmann E., et al. Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 246 (1999) 1186-1193
14. Berg D., Grote C., Rausch W.D., et al. Iron accumulation of the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol 25 (1999) 901-904
15. Berg D., Hoggenmuller U., Hofmann E., et al. The basal ganglia in haemochromatosis. Neuroradiology 42 (2000) 9-13
16. Berg D., Naumann M., Hoggenmuller U., et al. Differences of echogenicity and T2 relaxation time of the nucleus lentiformis in MSA and PSP as compared to Parkinson's disease. Mov Disord 15 Suppl 3 (2000) 206-207
17. Berg D., Weishaupt A., Francis M.J., et al. Changes of copper transporting proteins and ceruloplasmin in the lentiform nuclei in primary adult-onset dystonia. Ann Neurol 47 (2000) 827-830
18. Berg D., Siefker C., Ruprecht-Dorfler P., and Becker G. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 56 (2001) 13-17
19. Berg D., Jabs B., Merschdorf U., Beckmann H., and Becker G. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 50 (2001) 463-467
20. Berg D., Siefker C., and Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 8 (2001) 684-689
21. Berg D., Roggendorf W., Schroder U., et al. Echogenicity of the substantia nigra: Association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59 (2002) 999-1005
22. Berg D., Merz B., Reiners K., Naumann M., and Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 20 (2005) 383-385
23. Berland L.L., Bryan C.R., Sekar B.C., and Moss C.N. Sonographic examination of the adult brain. J Clin Ultrasound 16 (1988) 337-345
24. Dexter D.T., Jenner P., Schapira A.H.V., and Marsden C.D. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol 32 Suppl (1992) S94-S100
25. Double K.L., Gerlach M., Youdim M.B., and Riederer P. Impaired iron homeostasis in Parkinson's disease. J Neural Transm 60 Suppl (2000) 37-58
26. Durr A., Stevanin G., Cancel G., et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: Clinical, molecular, and neuropathological features. Ann Neurol 39 (1996) 490-499
27. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain 114 (1991) 2283-2301
28. Felletschin B., Bauer P., Walter U., et al. Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra. Neurosci Lett 352 (2003) 53-56
29. Furuhata H. New evolution of transcranial tomography (TCT) and transcranial color Doppler tomography (TCDT). Neurosonology 1 (1989) 8-15
30. Hilditch-Maguire P., Trettel F., Passani L.A., et al. Huntingtin: An iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet 9 (2000) 2789-2797
31. Hochstrasser H., Bauer P., Walter U., et al. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology 63 (2004) 1912-1917
32. Iova A., Garmashov A., Androuchtchenko N., et al. Postnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson's disease. J Neurol 251 (2004) 1451-1454
33. Jabs B.E., Berg D., Merschdorf U., Bartsch A.J., and Pfuhlmann B. Differences in substantia nigra echogenicity of nosological subtypes within the schizophrenic spectrum. A preliminary transcranial ultrasound study. Neuropsychobiology 44 (2001) 183-186
34. Kamphuisen H.A., Somer J.C., and Oosterbaan W.A. Two-dimensional echoencephalography with electronic sector scanning. Clinical experiences with a new method. J Neurol Neurosurg Psychiatry 35 (1972) 912-918
35. Kivi A., Trottenberg T., Kupsch A., et al. Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra. Mov Disord 20 (2005) 258-260
36. Kruse N., Berg D., Francis M.J., et al. Reduction of Menkes mRNA and copper in leukocytes of patients with primary adult-onset dystonia. Ann Neurol 49 (2001) 405-408
37. Naumann M., Becker G., Toyka K.V., Supprian T., and Reiners K. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 47 (1996) 1284-1290
38. Niehaus L., Savyer N., Weber U., et al. Brain parenchyma sonography in patients with essential tremor and Parkinson′s disease. Cerebrovasc Dis 17 Suppl 4 (2004) 3
39. Postert T., Lack B., Kuhn W., et al. Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography. J Neurol Neurosurg Psychiatry 67 (1999) 457-462
40. Postert T., Eyding J., Berg D., et al. Transcranial sonography in spinocerebellar ataxia type 3. J Neural Transm 68 Suppl (2004) 123-133
41. Puls I., Berg D., Maurer M., et al. Transcranial sonography of the brain parenchyma: comparison of B-mode imaging and tissue harmonic imaging. Ultrasound Med Biol 26 (2000) 189-194
42. Ruprecht-Dorfler P., Berg D., Tucha O., et al. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. NeuroImage 18 (2003) 416-422
43. Seidel G., Kaps M., Gerriets T., and Hutzelmann A. Evaluation of the ventricular system in adults by transcranial duplex sonography. J Neuroimaging 5 (1995) 105-108
44. Sommer U., Hummel T., Cormann K., et al. Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT. Mov Disord 19 (2004) 1196-1202
45. Walter U., Wittstock M., Benecke R., and Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 109 (2002) 191-196
46. Walter U., Niehaus L., Probst T., et al. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 60 (2003) 74-77
47. Walter U., Dressler D., Wolters A., et al. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 63 (2004) 504-509
48. Walter U., Klein C., Hilker R., et al. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 19 (2004) 1445-1449
49. Walter U., Krolikowski K., Tarnacka B., et al. Sonographic detection of basal ganglia abnormalities in asymptomatic and symptomatic Wilson disease. Neurology 64 (2005) 1726-1732